Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  New England Journal of Medicine

• Publication date

  2003-06-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMOA023161PMID 12826636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prednisone After Emergency Treatment of COPD

  2004cited by this paper
• The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: a population-based study.

  2002cited by this paper
• Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation.

  2002cited by this paper
• Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD.

  2002cited by this paper
• Hospital re-admission in patients with acute exacerbation of chronic obstructive pulmonary disease.

  2001cited by this paper
• Corticosteroids for preventing relapse following acute exacerbations of asthma.

  2001cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

  2001cited by this paper
• Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.

  2001cited by this paper
• Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

  2000cited by this paper
• Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment.

  2000cited by this paper
• Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease.

  1999cited by this paper
• Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

  1999cited by this paper
• Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease.

  1998cited by this paper
• Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease.

  1997cited by this paper
• Allergic respiratory disease: strategic targets for primary prevention during childhood.

  1997cited by this paper
• Adverse effects of corticosteroid therapy for COPD. A critical review.

  1997cited by this paper
• Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.

  1996cited by this paper
• Spirometry and dyspnea in patients with COPD. When small differences mean little.

  1996cited by this paper
• A multivariate model for the prediction of relapse after outpatient treatment of decompensated chronic obstructive pulmonary disease.

  1992cited by this paper
• Emergency department return visits in chronic obstructive pulmonary disease: the importance of psychosocial factors.

  1991cited by this paper
• Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma.

  1991cited by this paper
• Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

  1987cited by this paper
• Standardization of spirometry--1987 update. Statement of the American Thoracic Society.

  1987cited by this paper
• The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes.

  1984cited by this paper

• Cumulative Dispensing of Oral Corticosteroids Over 12 Months in People with COPD

  2025cites this paper
• Effects of glucocorticoid administration routes on patients with acute exacerbations of chronic obstructive pulmonary disease in China: A propensity score-matched longitudinal analysis.

  2025cites this paper
• Management of severe exacerbations of COPD by French intensivists and adherence to guidelines.

  2025cites this paper
• The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

  2025cites this paper
• Effects of Short-Term Exposure to High-Dose Inhaled Corticosteroids on Appetite, Dietary Intake, Leptin Levels, and Body Weight in Adults with Asthma—A Prospective Pilot Study

  2025cites this paper
• Reduction in systemic glucocorticoid utilization among COPD patients with type 2 inflammation treated with biologics

  2025cites this paper
• Management of Asthma and COPD Exacerbations in Adults in the ICU

  2024cites this paper
• Hipertensión arterial pulmonar

  2024cites this paper
• Treatment with systemic corticosteroid versus placebo for exacerbations of COPD: A systematic review and meta-analysis.

  2024cites this paper
• [Efficacy and toxicity of short-course corticosteroid therapy in chronic bronchial diseases].

  2024cites this paper
• Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD

  2024cites this paper
• Effect of a Single Dose of Deflazacort on Postoperative Pain, Swelling, and Trismus after Impacted Lower Third Molar Surgery: Randomised Clinical Trial

  2024cites this paper
• The Exacerbation, Not the Patient, Determines Chronic Obstructive Pulmonary Disease Exacerbation Care Seeking

  2024cites this paper
• Exacerbations of COPD

  2023cites this paper
• Eosinophils and therapeutic responses to steroids and biologics in COPD: a complex relationship

  2023cites this paper
• Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial.

  2023cites this paper
• A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD

  2023cites this paper
• Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.

  2023cites this paper
• Impact of corticosteroids on the duration of ventilatory support during severe acute exacerbations of chronic obstructive pulmonary disease in patients in the intensive care unit: a study protocol for a multicentre, randomized, placebo-controlled, double-blind trial

  2023cites this paper
• Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

  2023cites this paper
• Efficacy and safety of oral corticosteroids to treat outpatients with acute exacerbations of COPD in primary care: a multicentre pragmatic randomised controlled study

  2023cites this paper
• Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

  2023cites this paper
• Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations

  2023cites this paper
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

  2023cites this paper
• Gold 2023: Highlights for primary care

  2023cites this paper
• Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC

  2022cites this paper
• Balance impairment and lower limbs strength in patients with COPD who fell in the previous year.

  2022cites this paper
• How and when to manage respiratory infections out of hospital

  2022cites this paper
• Corticosteroid administration and glycemic outcomes during treatment of acute exacerbation of chronic obstructive pulmonary disease

  2022cites this paper
• Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis

  2022cites this paper
• Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations.

  2021cites this paper
• Effects of Empirical Glucocorticoid Use on Severe Acute Exacerbation of COPD During Hospitalization

  2021cites this paper
• Prednisolone

  2021cites this paper
• Aktualisierte S3-Leitlinie „Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung“

  2020cites this paper
• Chronic Obstructive Pulmonary Disease: A palliative medicine review of the disease, its therapies and drug interactions.

  2020cites this paper
• Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Treatment of severe stable COPD: the multidimensional approach of treatable traits

  2020cites this paper
• Predicting Severe COPD Exacerbations: Developing a Population Surveillance Approach with Administrative Data.

  2020cites this paper
• Efficacy and Safety of Different Doses of Systemic Corticosteroids in COPD Exacerbation

  2020influential citation
• Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease

  2020cites this paper
• How should vulnerable people be protected during wildfires?

  2020cites this paper
• How may we improve clinical outcomes for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease? A narrative review about possible therapeutic and preventive strategies

  2020cites this paper
• COPD_A_236305 567..574

  2020cites this paper
• Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?

  2020cites this paper
• Comparison of two scores of short term serious outcome in COPD patients.

  2020cites this paper
• Impact of the implementation of a pharmacist-driven chronic obstructive pulmonary disease exacerbation orderset in an inpatient setting.

  2020cites this paper
• GOLD 2018 Report: A Review

  2019cites this paper
• Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic Review

  2019influential citation
• Acute Exacerbation of COPD

  2019cites this paper
• Noninvasive versus invasive ventilation in weaning of patients with type 2 respiratory failure

  2019cites this paper
• Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)

  2019cites this paper
• Building toolkits for COPD exacerbations: lessons from the past and present

  2019cites this paper
• Systemic Corticosteroids during Acute Exacerbations of Chronic Obstructive Pulmonary Disease ( COPD ) ?

  2019influential citation
• Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD

  2018cites this paper
• Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission

  2018cites this paper
• Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study

  2018cites this paper
• Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD

  2018cites this paper
• Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)? CON

  2018influential citation
• Whole-genome methylation profiling of peripheral blood mononuclear cell for acute exacerbations of chronic obstructive pulmonary disease treated with corticosteroid

  2018cites this paper
• Fatal strongyloidiasis after corticosteroid therapy for presumed chronic obstructive pulmonary disease

  2018cites this paper
• Systemic Corticosteroid and Antibiotic Use in Hospitalized Patients With Chronic Obstructive Pulmonary Disease Exacerbation

  2018cites this paper
• Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department

  2018cites this paper
• Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.

  2018cites this paper
• [Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology].

  2018cites this paper
• Chapter 2 Airways inflammation and its treatment during acute exacerbations of COPD

  2018cites this paper
• Edinburgh Research Explorer Airways inflammation and treatment during acute exacerbations of COPD

  2018cites this paper
• Clinical Pharmacology of Corticosteroids

  2018cites this paper
• The Top 10 Pulmonary Pearls for Primary Care Physicians

  2018cites this paper
• Management of severe acute exacerbations of COPD: an updated narrative review

  2018influential citation
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

  2017cites this paper
• Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis

  2017cites this paper
• Randomized Double‐Blind Controlled Trial of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2017cites this paper
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

  2017cites this paper
• Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report

  2017cites this paper
• Acute Exacerbation of COPD: Non-invasive Positive Pressure Ventilation

  2017cites this paper
• Outpatient Management for Acute Exacerbations of Obstructive Lung Diseases.

  2017cites this paper
• [Systemic corticosteroids during acute COPD exacerbations].

  2017cites this paper
• Medicina basada en la no-evidencia: el ejemplo del uso de los corticosteroides sistémicos en la agudización de la EPOC

  2017cites this paper
• High doses of systemic corticosteroids in patients hospitalized for exacerbation of chronic obstructive pulmonary disease. A cohort study

  2017cites this paper
• Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

  2017cites this paper
• Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT‐proBNP

  2017cites this paper
• Dosis altas de corticoides sistémicos en pacientes ingresados por exacerbación de enfermedad pulmonar obstructiva crónica. Un estudio de cohortes

  2017cites this paper
• Patterns and characterization of COPD exacerbations using real-time data collection

  2017cites this paper
• COPD: definition, severity and impact of pulmonary exacerbations

  2017cites this paper
• Steroids for Treatment of COPD Exacerbations

  2017cites this paper
• Preventing Hospitalizations From Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2017cites this paper
• Non-evidence based medicine: example of the use of systemic corticosteroids in exacerbation of COPD.

  2017cites this paper
• Ein Antibiotikum gehört bei COPD nicht zur Standardtherapie

  2017cites this paper
• High doses of systemic corticosteroids in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. A cohort study.

  2017cites this paper
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

  2017cites this paper
• Emergency Department Management of Heart Failure and COPD: A National Survey of Attitudes and Practice.

  2016cites this paper
• Do Veterans Health Administration Enrollees Generalize to Other Populations?

  2016cites this paper
• Correction: Effects of Two Chinese Herbal Formulae for the Treatment of Moderate to Severe Stable Chronic Obstructive Pulmonary Disease: A Multicenter, Double-Blind, Randomized Controlled Trial

  2016cites this paper
• A statistical framework for modeling asthma and COPD biological heterogeneity, and a novel variable selection method for model-based clustering

  2016cites this paper
• Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

  2016cites this paper
• The clinical management of lower respiratory tract infections

  2016cites this paper
• Effect of Randomized Clinical Trial Findings on Emergency Management.

  2016cites this paper
• The clinical management of COPD exacerbations: an update

  2016cites this paper
• Single-Center Retrospective Evaluation of Inhaled Corticosteroid Use for Chronic Obstructive Pulmonary Disease Exacerbation Patients Receiving Systemic Corticosteroids

  2016cites this paper